USFDA

USFDA approves Pfizer’s Hympavzi for rare bleeding disorder hemophilia

October 11, 2024

[ad_1] Analysts expect sales of Hympavzi to reach $300 million by 2030, according to estimates compiled by LSEG. (Photo: Reuters)2 min read Last Updated : Oct 11 2024 | 11:42...

Indoco Remedies shares rise over 3% on USFDA nod for allergy drug

October 4, 2024

[ad_1] 3 min read Last Updated : Oct 04 2024 | 1:35 PM IST Mumbai based pharmaceutical company Indoco Remedies share price surged 3.13 per cent at Rs 349.95 per...